Trial Details
TERMINATEDBasic Information
| Clinical ID | c3748 |
|---|---|
| Identifier | NCT01577264 |
| Trial Title | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Rheumatoid Arthritis|Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Kazan' |
| Country/Region | Russia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2011-08 |
|---|---|
| Primary Completion Date | 2015-10 |
| Completion Date | 2015-10 |